Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: Wally Mastroly who wrote (1609)	9/9/1998 1:04:00 PM
From: Jesse	Read Replies (1) \| Respond to of 4140

ALL: I have followed this company for a while ..... getting a lot of good information from many on this thread. Thank you. I know it's been discussed, however perhaps someone can outline for me the impact of the Visx FDA panel approval for treatment of farsightness, and how this impacts SNRS. Do both systems address the same levels of farsightness, are the equally effective, is this information known yet, what are the cost differences for both machine and procedure? Thank you for any input. Jesse